An adverse reaction to buprenorphine/naloxone induction in prison: A case report
Date of Original Version
Buprenorphine is an effective treatment for opiate dependence. Prisoners with histories of opiate dependence who are inducted on buprenorphine prior to release are at decreased risk of post-release relapse and overdose, yet many clinicians are unaware of the risks related to buprenorphine induction for non-opiate tolerant patients, especially those on other psychotropic medications. The authors report a case of probable non-lethal overdose during dose induction of a non-tolerant prisoner and discuss appropriate dosing under similar circumstances. Copyright © 2011 by Lippincott Williams & Wilkins.
Addictive Disorders and their Treatment
Rich, Josiah D., Michelle McKenzie, Samuel Dickman, Jeffrey Bratberg, Joshua D. Lee, and Robert P. Schwartz. "An adverse reaction to buprenorphine/naloxone induction in prison: A case report." Addictive Disorders and their Treatment 10, 4 (2011): 199-200. doi:10.1097/ADT.0b013e3182133949.